أعرض في EDS

Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

التفاصيل البيبلوغرافية
العنوان:	Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]
المؤلفون:	König, D, Schär, S, Vuong, Diem, Guckenberger, Matthias, Furrer, K, Opitz, I, Weder, W, Rothschild, S I, Ochsenbein, A, Zippelius, A, Addeo, A, Mark, M, Eboulet, E I, Hayoz, S, Thierstein, S, Betticher, D C, Ris, H-B, Stupp, R, Curioni-Fontecedro, A, Peters, S, Pless, M, Früh, M
المساهمون:	University of Zurich, König, D
المصدر:	König, D; Schär, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO open, 7(3), p. 100494. Elsevier 10.1016/j.esmoop.2022.100494 <http://dx.doi.org/10.1016/j.esmoop.2022.100494>
بيانات النشر:	BMJ Publishing Group, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	10255 Clinic for Thoracic Surgery, 2730 Oncology, 1306 Cancer Research, 610 Medicine & health, 10044 Clinic for Radiation Oncology
وصف الملف:	application/pdf; 2022_Koenig_35468561.pdf - application/pdf
DOI:	10.5167/uzh-220870
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7758c5e0f3b2ce34c3c65c55ccb36d
حقوق:	OPEN
رقم الأكسشن:	edsair.doi.dedup.....7b7758c5e0f3b2ce34c3c65c55ccb36d
قاعدة البيانات:	OpenAIRE

الوصف
DOI:	10.5167/uzh-220870